HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Dermatology1 paper

Malignant melanoma in precancerous melanosis

Last edited: 4/10/2026

Overview

This summary addresses malignant melanoma in the context of precancerous melanosis, focusing on risk factors and associations with other skin conditions. While precancerous melanosis is a precursor to melanoma, the provided abstracts do not directly discuss its management or specific diagnostic criteria. Instead, they offer insights into factors influencing melanoma risk, such as hair color and the presence of vitiligo.

Diagnosis

Management

Special Populations

Key Recommendations

  • Light hair colors (red, blonde, light brown) are associated with an increased risk of cutaneous melanoma and keratinocyte skin cancer 2.
  • Dark brown hair shows an inverse causal relationship with both cutaneous melanoma and keratinocyte skin cancer 2.
  • Black hair is associated with a decreased risk of keratinocyte skin cancer but shows no causal relationship with cutaneous melanoma 2.
  • Patients with vitiligo may have a reduced incidence of both melanoma and nonmelanoma skin cancer, potentially due to immune-mediated or nonimmune-mediated pathways 1.

    • References

    1 Rooker A, Ouwerkerk W, Bekkenk MW, Luiten RM, Bakker WJ. The Risk of Keratinocyte Cancer in Vitiligo and the Potential Mechanisms Involved. The Journal of investigative dermatology 2024. link 2 Wang S, Chen J, Jin Z, Xing Y, Wang R. Natural hair color and skin cancers: A two-sample Mendelian randomization study. Gene 2024. link

    Original source

    1. [1]
      The Risk of Keratinocyte Cancer in Vitiligo and the Potential Mechanisms Involved. — Rooker A, Ouwerkerk W, Bekkenk MW, Luiten RM, Bakker WJ The Journal of investigative dermatology (2024)
    2. [2]
      Natural hair color and skin cancers: A two-sample Mendelian randomization study. — Wang S, Chen J, Jin Z, Xing Y, Wang R Gene (2024)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG